Skip to content

Total debt at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$5.4B-0.1%
Alkermes logo
AlkermesALKS
$1.58B+2,034%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$219.9M+4.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.42M-42.5%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.57B+17.7%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$50.79M-9.3%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s total debt?
Harmony Biosciences Holdings, Inc. (HRMY) reported total debt of $164.61M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s total debt changed year-over-year?
Harmony Biosciences Holdings, Inc.'s total debt decreased by 7.2% year-over-year, from $177.46M to $164.61M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total debt?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s total debt has grown at a -2.7% compound annual growth rate (CAGR), from $194.25M to $169.25M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.